Pharma stocks rise amid market drop due to limited impact from US pricing order. Discover more on what fuels this…
Trump’s previous attempt to implement international reference pricing during his first term was blocked in court, though it was estimated…
Nifty Pharma share price today, May 12: Pharma stocks fall as Trump plans to slash US drug prices. Discover more…
The pharma stocks in India see significant selloff after US President Donald Trump signs executive orders promoting active and faster…
The proposed merger between Suven Pharmaceuticals and Cohance Lifesciences will be effective from May 1, 2025. Suven Pharmaceuticals said that…
Indian pharma firms eye full exemption from US reciprocal tariffs amid a 90-day breather, citing America’s heavy reliance on affordable…
India Plans Logistics Overhaul for Pharma and Medical Devices Amid US Tariff Concerns. Even as the pharma industry navigates potential…
Healthcare costs in India are expected to rise by 13% in 2025, surpassing the global average of 10% and the…
Emcure Pharmaceuticals acquires UK-based Manx Healthcare for £19.7 million, expanding its portfolio in generics and OTC products. The company also…
India’s pharmaceutical sector benefits from the US excluding it from reciprocal tariffs, securing affordable medicines. However, medical device exports face…
In FY24, Indian pharmaceutical exports to the U.S. were valued at approximately USD 8 billion, with the industry witnessing an…
According to analytics firm IQVIA, Indian generics saved the US healthcare system $219 billion in 2022 and $1.3 trillion between…
IgAN is a progressive, rare kidney disease in which the immune system attacks the kidneys, often causing glomerular inflammation and…
Presently, India imposes 10 percent tariff on Pharma imports from the United States. The US doesn’t impose any tariff on…
The company said it will expand its weight-loss offerings with branded versions of Lilly’s tirzepatide.
Jefferies maintains that companies with mixed revenue streams, such as specialty pharma, biosimilars, and inhalers, may face some impact.
The company is expanding its cardiology portfolio with a new treatment for transthyretin amyloid cardiomyopathy in Europe.
The US report criticizes India’s drug price controls on medical devices like stents and knee implants, citing concerns over inflation…